Comparing Oxybutynin vs Sanctura
| Oxybutynin | Sanctura (trospium) |
|
|---|
| Oxybutynin | Sanctura (trospium) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription and OTC
Oxybutynin helps to relieve symptoms of an overactive bladder and urinary incontinence but it may cause side effects such as a dry mouth and constipation. Prescribed for Overactive Bladder... View more |
Prescription only
Prescribed for Urinary Incontinence, Interstitial Cystitis, Urinary Frequency. Sanctura may also be used for purposes not listed in this medication guide. |
Related suggestions Urinary Frequency
Urinary Incontinence
Popular comparisons
|
|||||||
| More about Oxybutynin | More about Sanctura (trospium) | ||||||||
| Ratings & Reviews | |||||||||
|
Oxybutynin has an average rating of 6.7 out of 10 from a total of 461 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 24% reported a negative effect. |
Sanctura has an average rating of 7.5 out of 10 from a total of 22 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Oxybutynin side effects |
View all Sanctura side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Oxybutynin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Oxytrol, Oxytrol for Women |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
2.3 hours |
20 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 287 drugs are known to interact with Oxybutynin:
|
A total of 317 drugs are known to interact with Sanctura:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
July 16, 1975 |
May 28, 2004 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Myrbetriq
Myrbetriq (mirabegron) is used to treat overactive bladder with symptoms of frequent or urgent ...
Gemtesa
Gemtesa (vibegron) is used to treat overactive bladder symptoms (OAB) in adults or men taking ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
VESIcare
Vesicare is used to treat symptoms of overactive bladder such as incontinence and frequent ...
Trospium
Trospium is used for interstitial cystitis, overactive bladder, urinary frequency, urinary incontinence
Tolterodine
Tolterodine is used for overactive bladder, urinary frequency, urinary incontinence
Mirabegron
Mirabegron is used for neurogenic detrusor overactivity, overactive bladder, urinary frequency ...
Solifenacin
Solifenacin (Vesicare) is used to treat overactive bladder symptoms such as frequent or urgent ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.